BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29140689)

  • 1. Tissue Inhibitor of Metalloprotease-2 (TIMP-2): Bioprocess Development, Physicochemical, Biochemical, and Biological Characterization of Highly Expressed Recombinant Protein.
    Chowdhury A; Brinson R; Wei B; Stetler-Stevenson WG
    Biochemistry; 2017 Dec; 56(49):6423-6433. PubMed ID: 29140689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for the mechanism of TIMP functions.
    Wingfield PT; Sax JK; Stahl SJ; Kaufman J; Palmer I; Chung V; Corcoran ML; Kleiner DE; Stetler-Stevenson WG
    J Biol Chem; 1999 Jul; 274(30):21362-8. PubMed ID: 10409697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of bioactive his6-tagged recombinant human tissue inhibitor of metalloproteinases-1 (TIMP-1) protein expressed at high yields in mammalian cells.
    Vinther L; Lademann U; Andersen EV; Højrup P; Thaysen-Andersen M; Krogh BO; Viuff B; Brünner N; Stenvang J; Moreira JM
    Protein Expr Purif; 2014 Sep; 101():157-64. PubMed ID: 24998777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agent.
    Van Steenkiste M; Oltenfreiter R; Frankenne F; Vervoort L; Maquoi E; Noel A; Foidart JM; Van De Wiele C; De Vos F
    Cancer Biother Radiopharm; 2010 Oct; 25(5):511-20. PubMed ID: 20854210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1).
    Batra J; Robinson J; Mehner C; Hockla A; Miller E; Radisky DC; Radisky ES
    PLoS One; 2012; 7(11):e50028. PubMed ID: 23185522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system activation and imbalance of matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 in cold-induced stroke.
    Su YY; Li HM; Yan ZX; Li MC; Wei JP; Zheng WX; Liu SQ; Deng YT; Xie HF; Li CG
    Life Sci; 2019 Aug; 231():116563. PubMed ID: 31200003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a protein engineering strategy to overcome limitations in the production of "Difficult to Express" recombinant proteins.
    Hussain H; Fisher DI; Abbott WM; Roth RG; Dickson AJ
    Biotechnol Bioeng; 2017 Oct; 114(10):2348-2359. PubMed ID: 28627739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L; Tanaka M; Wait R; Shi YE; Brew K; Nagase H
    Biochemistry; 2002 Dec; 41(50):15025-35. PubMed ID: 12475252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling.
    Rossi L; Forte D; Migliardi G; Salvestrini V; Buzzi M; Ricciardi MR; Licchetta R; Tafuri A; Bicciato S; Cavo M; Catani L; Lemoli RM; Curti A
    Exp Hematol; 2015 Nov; 43(11):974-985.e1. PubMed ID: 26213230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism.
    Lafleur MA; Tester AM; Thompson EW
    FEBS Lett; 2003 Oct; 553(3):457-63. PubMed ID: 14572669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
    Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
    Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinase-2 (TIMP-2) from red seabream (Pagrus major): Molecular cloning and biochemical characterization of highly expressed recombinant protein.
    Zhong C; Cao MJ; Shu M; Sun LC; Yang HH; Wu GP
    Fish Shellfish Immunol; 2019 Dec; 95():556-563. PubMed ID: 31693944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macromolecule-Network Electrostatics Controlling Delivery of the Biotherapeutic Cell Modulator TIMP-2.
    Yamada Y; Chowdhury A; Schneider JP; Stetler-Stevenson WG
    Biomacromolecules; 2018 Apr; 19(4):1285-1293. PubMed ID: 29505725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct expression of active human tissue inhibitors of metalloproteinases by periplasmic secretion in Escherichia coli.
    Lee KB; Nam DH; Nuhn JAM; Wang J; Schneider IC; Ge X
    Microb Cell Fact; 2017 Apr; 16(1):73. PubMed ID: 28454584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminus of collagenase MMP-8 determines superactivity and inhibition: a relation of structure and function analyzed by biomolecular interaction analysis.
    Farr M; Pieper M; Calvete J; Tschesche H
    Biochemistry; 1999 Jun; 38(22):7332-8. PubMed ID: 10353844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo activity of human recombinant tissue inhibitor of metalloproteinases (TIMP). Activity against human stromelysin in vitro and in the rat pleural cavity.
    Lark MW; Saphos CA; Walakovits LA; Moore VL
    Biochem Pharmacol; 1990 Jun; 39(12):2041-9. PubMed ID: 2353943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.